Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

LPTX

Leap Therapeutics (LPTX)

Leap Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LPTX
DataHoraFonteTítuloCódigoCompanhia
06/01/202509:00PR Newswire (US)Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
26/11/202409:00PR Newswire (US)Leap Therapeutics to Participate at Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
13/11/202409:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LPTXLeap Therapeutics Inc
13/11/202409:00PR Newswire (US)Leap Therapeutics Reports Third Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
13/11/202408:50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LPTXLeap Therapeutics Inc
06/11/202418:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LPTXLeap Therapeutics Inc
31/10/202419:29Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LPTXLeap Therapeutics Inc
31/10/202418:40Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:LPTXLeap Therapeutics Inc
04/10/202418:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LPTXLeap Therapeutics Inc
30/09/202408:00PR Newswire (US)Leap Therapeutics Announces Completion of Enrollment in Part B of the DeFianCe Study of DKN-01 for the Treatment of Colorectal Cancer PatientsNASDAQ:LPTXLeap Therapeutics Inc
12/08/202408:00PR Newswire (US)Leap Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
24/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LPTXLeap Therapeutics Inc
23/05/202417:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LPTXLeap Therapeutics Inc
13/05/202408:00PR Newswire (US)Leap Therapeutics Reports First Quarter 2024 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
10/05/202418:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LPTXLeap Therapeutics Inc
11/04/202409:30PR Newswire (US)Leap Therapeutics Announces $40 Million Private PlacementNASDAQ:LPTXLeap Therapeutics Inc
18/03/202408:00PR Newswire (US)Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
16/01/202419:05PR Newswire (US)Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers SymposiumNASDAQ:LPTXLeap Therapeutics Inc
03/01/202409:00PR Newswire (US)Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
02/01/202409:00PR Newswire (US)Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer PatientsNASDAQ:LPTXLeap Therapeutics Inc
11/12/202318:05PR Newswire (US)Leap Therapeutics to Present New Data from Part A of the DeFianCe Study of DKN-01 Plus Bevacizumab and Chemotherapy in Colorectal Cancer Patients at the 2024 ASCO Gastrointestinal Cancers SymposiumNASDAQ:LPTXLeap Therapeutics Inc
21/11/202309:00PR Newswire (US)Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:LPTXLeap Therapeutics Inc
13/11/202309:00PR Newswire (US)Leap Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
05/09/202308:00PR Newswire (US)Leap Therapeutics to Participate at Upcoming Investor ConferencesNASDAQ:LPTXLeap Therapeutics Inc
14/08/202308:00PR Newswire (US)Leap Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:LPTXLeap Therapeutics Inc
12/07/202308:00PR Newswire (US)Leap Therapeutics Announces Initiation of Randomized Controlled Part B of the DeFianCe Study of DKN-01 in Colorectal Cancer PatientsNASDAQ:LPTXLeap Therapeutics Inc
20/06/202313:30PR Newswire (US)Leap Therapeutics Announces Reverse Stock SplitNASDAQ:LPTXLeap Therapeutics Inc
15/06/202307:26Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LPTXLeap Therapeutics Inc
14/06/202317:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LPTXLeap Therapeutics Inc
09/06/202317:11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:LPTXLeap Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LPTX